Table. Characteristics of blaVIM-1-bearing Acinetobacter baumannii isolates*†.
| Isolate no. | Region of isolation | Material | PFGE type | Etest IMP MIC (μg/mL) | Etest MBL (IMP+EDTA) | Etest MER MIC (μg/mL) | blaOXA-51-like status | blaOXA-58 status |
|---|---|---|---|---|---|---|---|---|
| 1 | Thessaloniki | Blood | Ia | 4 | <1 | 2 | + | – |
| 2 | Thessalia | Bronchial fluid | II | 32 | 2 | 4 | + | + |
| 3 | Thessalia | CSF | III | 4 | <1 | 2 | – | – |
| 4 | Thessalia | Blood | IV | >32 | 1 | 32 | + | – |
| 5 | Thessaloniki | Urine | Ib | 8 | <1 | 4 | + | + |
*The 5 isolates exhibited resistance to all alternative antimicrobial drugs except colistin. †PFGE, pulsed-field gel electrophoresis; IMP, imipenem; MBL, metallo-β-lactamase; MER, meropenem; CSF, cerebrospinal fluid.